Drug Type Small molecule drug |
Synonyms HIF-143 |
Target |
Action inhibitors |
Mechanism cyt bc1 inhibitors(Cytochrome bc1 complex inhibitors) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Cancer | Preclinical | South Korea | 15 Apr 2012 |